| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.004 | 0.9 |